SA
Go ProLog In
LBRX
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$36.00
+32.0%
Consensus
$38.50
+41.2%
Bull
$45.00
+65.0%
12-Month Target Range1 analyst
$36.00$38.50$45.00
Current $27.27Consensus
Current Price
$27.27
Upside to Consensus
$11.23

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev—
EPS—
FY2028
Rev—
EPS—
FY2029
Rev—
EPS—

Earnings Surprises

Recent Analyst Actions

May 17, 2026Roth Capital
LB Pharmaceuticals price target raised to $37 from $31 at Roth Capital
Target:$37.00
+24.7%from $29.66
Apr 27, 2026H.C. Wainwright
LB Pharmaceuticals initiated with a Buy at H.C. Wainwright
Target:$45.00
+46.4%from $30.73
Apr 10, 2026Craig-Hallum
Craig-Hallum bullish on LB Pharmaceuticals, initiates with a Buy
Target:$36.00
+45.8%from $24.68
Mar 27, 2026Stifel Nicolaus
LB Pharmaceuticals price target raised to $40 from $35 at Stifel
Target:$40.00
+67.8%from $23.84
Jan 9, 2026Roth Capital
LB Pharmaceuticals initiated with a Buy at Roth Capital
Target:$31.00
+49.0%from $20.80
Dec 11, 2025Stifel Nicolaus
LB Pharmaceuticals price target raised to $35 from $27 at Stifel
Target:$35.00
+63.9%from $21.36
Oct 6, 2025Leerink Partners
LB Pharmaceuticals initiated with an Outperform at Leerink
Target:$34.00
+125.9%from $15.05
Oct 6, 2025Stifel Nicolaus
LB Pharmaceuticals initiated with a Buy at Stifel
Target:$27.00
+79.4%from $15.05

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance